A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-22926-2
Affiliations:
15
Authors:
48
Institutions Authors Share
Nankai University (NKU), China
12.500000
12.500000
0.26
HiFiBio Limited - China, China
12.000000
12.000000
0.25
Wuhan Institute of Virology (WIV), CAS, China
10.000000
10.000000
0.21
Xinhua Hospital, SJTU, China
5.000000
0.10
Institute of Bioorganic Chemistry, RAS, Russia
2.000000
0.04
Tianjin International Joint Academy of Biomedicine (TJAB), China
2.000000
0.04
WuXi Biologics, China
1.000000
0.02
Shanghai Synchrotron Radiation Facility (SSRF), SINAP CAS, China
1.000000
0.02
Shanghai Advanced Research Institute (SARI), CAS, China
1.000000
0.02
Tsinghua University, China
1.000000
0.02
ShanghaiTech University, China
0.250000
0.01
Guangzhou Laboratory, China
0.250000
0.01